Berkshire Hathaway sells $133 billion of stocks
Warren Buffett’s
Apple:
American Express:
Coca-Cola:
During the 2024 shareholders’ meeting, Buffett said he found it “quite attractive” to build a larger cash position as the stock market continued to rise.
With valuations becoming more expensive, the pool of quality businesses selling at sensible prices is limited. Buffett has not sold a single share of Coca-Cola or American Express in over 25 years. Coca-Cola is one of Berkshire’s longest-held investments, originally bought in the late 1980s.
Despite shifting consumer preferences, the company has driven growth across a large lineup of beverages. Over 2 billion servings of Coca-Cola’s products are consumed every day, resulting in consistent revenue and profits. The stock’s pullback has brought its forward dividend yield to an attractive 3%.
Berkshire is set to make
Berkshire shifts strategy, raises cash
In Q3, American Express delivered solid financial results, with revenue reaching a new record and growing 8% year over year. The company acquired 3.3 million new customers in Q3, up from 2.9 million in Q3 2023.
The
Buffett is renowned for his buy-and-hold strategy, prioritizing finding and buying quality stocks at fair prices and holding them for the long term. In 2024,
However, a more telling move was Buffett’s decision to sell shares, including a substantial amount in
The most critical takeaway from Berkshire Hathaway’s 2024 moves is Warren Buffett’s preparedness for future opportunities. While no one can predict exactly when asset prices will become attractive, Berkshire is ready to make significant investments when the time comes.
Related Posts
The post
The views expressed in content distributed by Newstex and its re-distributors (collectively, "Newstex Authoritative Content") are solely those of the respective author(s) and not necessarily the views of Newstex et al. It is provided as general information only on an "AS IS" basis, without warranties and conferring no rights, which should not be relied upon as professional advice. Newstex et al. make no claims, promises or guarantees regarding its accuracy or completeness, nor as to the quality of the opinions and commentary contained therein.
Proposed law eliminates monopoly on pharmaceutical delivery chain
Is Canada A Canary In The Economic Coalmine?
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News